EMCURE — Emcure Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹345.39bn
- IN₹359.40bn
- IN₹92.04bn
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees
Brief: Emcure Pharmaceuticals And Roche Sign Distribution Agreement In India
Brief: Emcure Pharmaceuticals Dec-Quarter Consol Net Profit 2.31 Billion Rupees
Focus: Lilly, Novo lock horns in India's obesity drug race
Brief: Emcure Pharmaceuticals Says Gujarat Facility Receives 'No Action Indicated' From US FDA
Brief: Emcure Pharmaceuticals Launches Poviztra Semaglutide Injection In India
Brief: Emcure Pharmaceuticals says GST Department Conducts Search At Emcure Offices
India's Emcure Pharmaceuticals drops after block deals at discount
Novo Nordisk, Emcure to launch weight-loss drug under new brand in India (updated)
India's Emcure Pharma gains on partnership with Novo Nordisk
Novo Nordisk to sell weight loss drug Poviztra in India
Brief: Emcure Pharmaceuticals Says Novo Nordisk Partners With Emcure To Commercialise Poviztra In India
Brief: Emcure Pharmaceuticals US FDA Inspection At Emcure's Gujarat Facility
Brief: Emcure Pharmaceuticals - Buys 4.1 Million Shares Held By Individuals In Zuventus
Emcure Pharmaceuticals rises on BOB Capital's bullish initiation, Sanofi tie-up
Indian drugmakers Dr Reddy's, Hetero to sell generic HIV prevention drug for $40 a year